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CrosslinkingWe provide evidence to show that the standard reactant concentrations used in tissue engineering to
cross-link collagen-based scaffolds are up to 100 times higher than required for mechanical integrity
in service, and stability against degradation in an aqueous environment. We demonstrate this with a
detailed and systematic study by comparing scaffolds made from (a) collagen from two different suppli-
ers, (b) gelatin (a partially denatured collagen) and (c) 50% collagen–50% gelatin mixtures. The materials
were processed, using lyophilisation, to produce homogeneous, highly porous scaffolds with isotropic
architectures and pore diameters ranging from 130 to 260 lm. Scaffolds were cross-linked using a
carbodiimide treatment, to establish the effect of the variations in crosslinking conditions (down to very
low concentrations) on the morphology, swelling, degradation and mechanical properties of the scaffolds.
Carbodiimide concentration of 11.5 mg/ml was deﬁned as the standard (100%) and was progressively
diluted down to 0.1%. It was found that 10-fold reduction in the carbodiimide content led to the signif-
icant increase (almost 4-fold) in the amount of free amine groups (primarily on collagen lysine residues)
without compromising mechanics and stability in water of all resultant scaffolds. The importance of this
ﬁnding is that, by reducing cross-linking, the corresponding cell-reactive carboxylate anions (collagen
glutamate or aspartate residues) that are essential for integrin-mediated binding remain intact. Indeed,
a 10-fold reduction in carbodiimide crosslinking resulted in near native-like cell attachment to collagen
scaffolds. We have demonstrated that controlling the degree of cross-linking, and hence retaining native
scaffold chemistry, offers a major step forward in the biological performance of collagen- and
gelatin-based tissue engineering scaffolds.
Statement of Signiﬁcance
This work developed collagen and gelatine-based scaffolds with structural, material and biological
properties suitable for use in myocardial tissue regeneration. The novelty and signiﬁcance of this research
consist in elucidating the effect of the composition, origin of collagen and crosslinking concentration on
the scaffold physical and cell-binding characteristics. We demonstrate that the standard carbodiimide
concentrations used to crosslink collagenous scaffolds are up to 100 times higher than required for
mechanical integrity in service, and stability against dissolution. The importance of this ﬁnding is that,
by reducing crosslinking, the corresponding cell-reactive carboxylate anions (essential for
integrin-mediated binding) remain intact and the native scaffold chemistry is retained. This offers a
major step forward in the biological performance of tissue engineered scaffolds.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The concept of tissue engineering (TE) has led to the utilisation
of 3D scaffolds as cell-delivery vehicles [1–6]. Ideally, thesebiomaterials should mimic the function of the extracellular matrix
(ECM) which not only provides mechanical support for cells, but
also supplies signals that direct cell attachment, proliferation, dif-
ferentiation and metabolism [7,8]. The main objective of this
research is to tailor the material properties of collagen-, gelatin-
and collagen–gelatin-based scaffolds by changing their composi-
tion and crosslink status. Collagen (Col) and gelatin (Gel) were
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senses; they are ideal materials for soft tissue engineering con-
structs. There is a considerable amount of literature in the ﬁeld
already [1–3,6,9,10] and these works are described are normally
based on a standardised route for cross-linking [6,10–12].
However, while this cross-linking step stabilises the mechanical-
and degradation properties of the materials in service, the major
drawback is the detrimental effects this may have on the biological
activity of the scaffold [9,11,12].
Collagen is the most abundant protein in the ECM of many hard
and soft tissues in the human body [13,14]. As examples collagen
accounts for 90% of bonematrix protein content [15] and comprises
up to80%ofmyocardial ECM [16,17]. Especially important is ﬁbrillar
Type I collagenwhich provides structural support to resident cells in
both soft and hard tissues. Collagen possesses the repetitive array of
receptor-recognitionmotifs, essential for cell interaction, where the
most important is GFOGER (where G is glycine, F is phenylalanine, O
is hydroxyproline, E is glutamate andR is arginine). This high afﬁnity
triple-helical motif interacts with cells via speciﬁc b1-binding
integrins, especially a1b1, a2b1, a10b1, a11b1 [18–22].
Gelatin, thermally denatured collagen, possesses more
disorganised structure which should affect material and mechani-
cal stability of the resultant scaffolds. Denaturation alters the
macromolecular order of collagen, but chemical composition is
closely maintained [22–24]. The destruction of the triple-helical
system and the formation of random-coiled domains in gelatin also
change the availability of cell-binding sites. Cell binding to the con-
formationally sensitive GFOGER motif is lost and instead the main
receptor-recognition motif presented to cells is RGD (where D is
aspartate) which signals to other integrins (mainly a5b1 and avb3)
[19,25,26]. As such the addition of gelatin to collagen can tailor
the material stability, swelling and mechanical properties of scaf-
folds and could be a design strategy for changing biochemical activ-
ity. Further means of controlling these properties could be through
the variation of the crosslinking status of these protein matrices.
Native collagen possesses multiple inter- and intramolecular
cross-links, so providing structural strength and durability to their
matrices in different biological environments. Extracting and puri-
fyingmethods applied for processing naturally derived collagen into
useful formsmarkedly reduce its cross-linking densitywith the con-
sequent impact on the relevant properties and biological response.
To improve structural stability andmechanics of collagenousmate-
rials different chemical (aldehydes, isocyanates, carbodiimides, etc.)
[9,11,27–31] and physical (ultraviolet irradiation, dehydrothermal
treatments, etc.) [32–36] methods could be used, none of which is
completely satisfactory. In this works the carbodiimide treatment,
EDC (1-ethyl-3-(3-dimethylaminopropyl-carbodiimide hydrochlo-
ride) in the presence of NHS (N-hydroxy-succinimide), at different
concentrations was selected for scaffold cross-linking (XL). This
method constitutes one of the most successful chemical crosslink-
ing treatments for collagen-based biomaterials aimed at TE applica-
tions as it is highly efﬁcient, nontoxic (EDC/NHS do not take part in
linkage), and the resultant by-products can be easily removed by
washing [9–11,31]. But, as EDC uses free primary amino groups
(on lysine residues) and cell-reactive carboxylate anions (on
glutamate or aspartate residues) for cross-linking [9,11,31] this
may diminish the availability of essential cell binding motifs on
collagen-type materials.
One of the goals of this work was the evaluation of the effect of
reducing the EDC concentration down to very low levels (up to 1000
times dilution with respect to standard condition: EDC concentra-
tion of 11.5 mg/ml with molar ratios EDC/NHS/COO(Col) = 5/2/1,
deﬁned as 100%) on scaffolds mechanics, dissolution behaviour
and cell reactivity to obtain matrices with a variety of material
and biological properties. The biological performance of collage-
nous materials before and after crosslinking with different EDCconcentrations was also assessed in this work by studying cell
adhesion on thin ﬁlms. These 2D systems were chosen as a model
for 3D scaffold struts. Human ﬁbrosarcoma (HT1080) and human
platelets were selected for this biological study.
The other important issue addressed in this study was the pos-
sible inﬂuence of the nature of the employed collagen on the rele-
vant characteristics of the resultant scaffolds (morphology,
dissolution resistance, mechanics, etc.). For this reason, Col-based
and mixed scaffolds were produced using two types of microﬁbril-
lar Col I obtained from different providers: Sigma (S) and Devro (D)
(Sigma–Aldrich Co. Ltd. UK and DevroMedical, respectively). Both
were of bovine origin but derived from different tissues: Sigma
Col was obtained from Achilles tendon while Devro sample was
extracted from the epidermis layer in skin. This suggests that differ-
ent processing/purifying methods were used for their production
whichmay unequally affect essential characteristics of theirmacro-
molecular triple-helical structure (ﬁbril lengths, width, entangle-
ment, etc.) with the consequent implication on the ﬁnal
properties of the scaffolds obtained from these collagens. The effect
of collagen origin on the behaviour of scaffolds produced from these
collagen samples after EDC treatment was evaluated on their mor-
phology, dissolution properties and resistance under compression.2. Materials and methods
2.1. Materials
Two type I microﬁbrillar collagens were used in this work. One
was derived from bovine dermal tissue (purchased from
DevroMedical) and the other from bovine Achilles tendon (obtained
from Sigma–Aldrich Co. Ltd., UK). Gelatin (type B from bovine skin,
Gel), acetic acid (2 M), 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimidehydrochloride (EDC), N-hydroxy-succinimide (NHS)
were purchased from Sigma Aldrich (UK). Other reagents were all
analytical grade, commercially available and used as received.
2.2. Scaffold preparation
Protein scaffolds (Col, Gel and Col/Gel = 50/50%-wt.) were
obtained by freeze-drying technique. Brieﬂy, collagen was swollen
in 0.05 M acetic acid at 4 C overnight to produce a 1% (w/v) pro-
tein suspension. The resulting suspension was homogenised on
ice for 30 min at 13,500 rpm using an Ultra-Turrax VD125 (VWR
International Ltd., UK). Air bubbles were removed from the suspen-
sion by centrifuging at 2500 rpm for 5 min (Hermle Z300,
Labortechnik, Germany). Gelatin solution, 1% (w/v), was prepared
by dissolving gelatin in 0.05 M acetic acid at 37–45 C with stirring
for 1 h (h). The solution was then cooled to room temperature with
stirring. The mixed collagen–gelatin 1:1 suspension was prepared
by mixing a gelatin solution with a collagen slurry (both 1% w/v),
homogenising for 15 min and centrifuging at the same conditions
as Col suspensions. All suspensions were then poured into silicone
trays (Lakeland, UK), to ensure ease of removal, and freeze-dried in
a VirTis adVantage bench-top freeze-drier (Biopharma Process
Systems, UK) using a cycle adapted from our previous work [10].
A constant cooling rate of 0.9 C/min to a ﬁnal freezing tempera-
ture of 26 C was used. The temperature was then held constant
at 26 C for 90 min. The ice phase was sublimed for 20 h under a
vacuum of less than 100 mTorr.
2.3. Scaffold crosslinking
Protein scaffolds (Col, Gel and Col/Gel = 50/50) were chemically
cross-linked using a water-soluble carbodiimide (EDC) in presence
of NHS at different concentrations. EDC concentration of
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EDC/NHS/COO(Col) = 5/2/1 was deﬁned as the standard condition
(100%). These cross-linking parameters (corresponding to 100%)
were selected on the basis of our previous results and also on the
reports from literature [6,10,11,37] recommended this
cross-linking condition as one of the best to achieve the highest
degrees of mechanical and material stabilisation for collagen-type
matrices. To obtain scaffolds with different cross-linked states the
EDC concentration was serially diluted in 10-fold steps from 100%
to 0.1%. After reaction in the corresponding EDC/NHS solution for
2 h at room temperature, the scaffolds were washed thoroughly
in deionised water (15 min  5) and were subsequently refrozen
and re-lyophilized using the previous freeze-drying cycle.
2.4. Morphology and dimensional properties
2.4.1. Morphology
Scanning electron microscopy (SEM) (JEOL 5800) was used to
analyse the internal architecture of scaffolds with different compo-
sitions and XL status. Longitudinal and transverse cross-sections
were cut from different part of scaffold sheet, mounted on stubs
and sputter coated with a layer of platinum for observation at
10 keV at various levels of magniﬁcation. Images were used to
compare the characteristics of scaffold porous structures (homo-
geneity, interconnectivity, etc.) and to determine their pore sizes
by the manual measurement of different pore zones (at least 30
pores randomly chosen from different microphotographs of each
sample).
2.4.2. Dimensional properties
Possible inﬂuences of composition, Col nature (S vs D) and EDC
treatment at standard concentration were assessed on the follow-
ing dimensional properties of scaffold: Relative density (q⁄/qs), cal-
culated from the measured dry density of the scaffold post
freeze-drying (q⁄ =m/V; wherem is the mass and V is the volume
of the 3D matrix) and the known dry density of solid collagen
(gelatine) (qs), assumed to be 1.3 g ml1) [28]. Porosity deﬁned as
the percentage of void space in a 3D sponge and determined from
relative density values [38]:
Porosity ð%Þ ¼ ð1 q=qsÞ  1002.5. Characterisation of collagen ﬁbre structure
2.5.1. Rheology
Viscosity measurements of 1% (w/v) protein slurries in 0.05 M
acetic acid were carried out by ARES controlled strain Rheometer
(TA Instruments, formerly Rheometrics Scientiﬁc Inc.) The tests
were performed using either a parallel plate geometry (plate diam-
eter 50 mm) or a couette geometry (cup diameter = 34 mm, bob
diameter = 32 mm, bob length = 34 mm). The temperature was
held at 20 C (controlled by a water jacket).
2.5.2. Confocal studies of peptide attachment to collagen ﬁbres
In order to assess the architecture of collagen ﬁbres slurries of
10 lg/ml of collagen (D and S) in 0.01 M acetic acid were prepared.
Polymeric type I collagen from bovine tendon (Ethicon Inc.,
Somerville NJ, USA), Ethicon, and soluble monomeric Col from calf
skin (Devro pty), were employed in the same concentrations as
positive and negative controls, respectively. Triple-helical
GFOGER peptide, used for attachment, was produced and
ﬂuorescein-labelled (FL) in the Biochemistry Department of
Cambridge University (Farndale laboratory) as described in
[39,40]. GFOGER-FL has an excitation wavelength of 492 nm and
emission of 517 nm.For observation by confocal microscopy, 100 ll of each collagen
suspension were pipetted individually to wells of an 8-well cham-
bered glass cover slip (Thermo Scientiﬁc – Lab Tech). After 2 h, the
unbound solution was removed and 200 ll of block solution
(50 mg/ml bovine albumin serum, BSA, in tri-buffered saline solu-
tion, TBS) was added to each well. After 1 h the block was removed
and the wells were washed with 200 ll of 0.1% (v/v) Tween in TBS
(3). 100 ll of GFOGER-FL (10 lg/ml of 0.1% Tween in TBS) were
added to the wells for attachment. After 1 h the solutions were
removed and the wells rinsed with 0.1% (v/v) Tween in TBS (3).
200 ll TBS were added to each well before observation in FTIC
mode using an Olympus FV300 laser-scanning confocal microscope
system, and IX81 inverted frame. Results were analysed using
Olympus Fluoview v5.0 software.
2.6. Amine group content and degree of cross-linking
The content of free primary amine groups present in the initial
non-crosslinked samples and those crosslinked with different EDC
concentrations was determined using a 2,4,6-trinitro-benzene-
sulfonic acid (TNBS) assay with a protocol similar to those reported
by Sashidar et al. [41] and Ofner et al. [42]. To each sample (2–
4 mg), 0.5 ml of a 4% (w/v) NaHCO3 solution and 0.5 ml of a freshly
prepared solution of 0.05% (w/v) TNBS were added. After 2 h at
40 C, 1.5 ml of 6 M HCl was added and the samples were hydrol-
ysed at 60 C for 90 min. The reactionmixture was diluted with dis-
tilled water (2.5 ml), cooled to room temperature, and A320 was
measured using a Fluostar Optima spectrophotometer. Controls
(blank samples) were prepared using the same procedure, except
that HCl was added, prior to introducing the TNBS solution, to pro-
hibit any reaction of TNBSwith the amine groups. The blank sample
value was subtracted from each sample absorbance. The absor-
bance was correlated to the concentration of free amine groups
using a calibration curve obtained with glycine in an aqueous
NaHCO3 solution. Three replicates were used for each determina-
tion and the number of amino groups per 1000 residues calculated.
The non-XL sample was assumed to contain 100% of the available
free amine groups and this value was used to calculate the percent-
age of remaining free amine groups after the crosslinking treat-
ment. The degree of crosslinking was evaluated as the difference
between the chemically-determined number of free amines groups
before and after crosslinking, relative to the initial free amine
content. In determining the degree of crosslinking, it has been
assumed that each lost amine group participates in one crosslink.
2.7. Dissolution in distilled water
This study was carried out in distilled water at 37 C. For this
test non-XL scaffolds and cross-linked with different EDC concen-
tration (from 0.1% to 100%) were produced from Sigma and
Devro collagens. Samples of approximately 5 mg were accurately
weighed (Mb) and submerged in 5 ml of water for different period
of time (up to 28 days). After different time intervals samples were
removed, dried to constant weight and weighed (Wa). The percent-
age weight loss was calculated as shown:
Weight loss ð%Þ ¼ 100 fðMbMaÞ=Mbg
Tests were repeated with four parallel samples each.
2.8. Mechanical testing
Compressive stress–stain analysis of the scaffolds was per-
formed in the wet stage using a mechanical Hounsﬁeld tester,
equipped with a 5 N load cell. Cylindrical specimens, of 8 mm
diameter and thickness of 6–8 mm, were cut from the scaffolds
and hydrated in deionised water at room temperature for 1 h prior
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the plane of the scaffold disc at a crosshead speed of 5 mmmin1.
The linear elastic (Young’s) modulus was obtained via linear
regression of the initial linear region of the stress–strain curve.
Five replica tests were made for each scaffold.
2.9. Cell studies
2.9.1. Film preparation
For cell studies ﬁlms of 8 lm of thickness were prepared by
drying 0.5% (w/v) suspensions of protein (Col(S), Col(S)-Gel and
Gel) directly in Immulon-2HB 96-well plates (100 ll of slurry/well)
for 48 h in a laminar ﬂow cabinet. These were EDC/NHS crosslinked
relative to the molarity of collagen carboxylic acid groups as for 3D
scaffolds.
2.9.2. Platelet adhesion analysis
Platelets were obtained from human platelet rich plasma pro-
vided by the National Health Service Blood and Transplants
(NHSBT) authority in accordance with the Declaration of
Helsinki. Platelets were prepared by centrifugation for 15 min,
240 g, the pellet discarded and 1 ll of Prostaglandin
E1(100 lg/ml in ethanol) added per ml of platelet supernatant.
The platelet suspension was centrifuged at 640 g for 10 min and
the cell pellet resuspended in tyrodes buffer (140 mM NaCl,
5.6 mM Glucose, 2 mM MgCl2, 0.4 mM NaH2PO4, 12 mM NaHCO3,
2.7 mM KCl, 10 mM HEPES pH 7.4) to a density of 1  108/ml.
Before platelet incubation, non-speciﬁc adsorption to the ﬁlm or
well was blocked with 200 ll of bovine serum albumin (BSA, 5%
(w/v) in PBS) for 60 min, and then washed three times with
200 ll of PBS. 100 ll of platelet suspension containing either
5 mMMg2+ or 5 mM EDTA, were added to wells and allowed to
attach at room temperature for 30 min. The wells were washed
with Tyrodes (200 ll  3) and then 150 ll of lysis buffer contain-
ing PNP phosphatase substrate (81 mM TriSodium Citrate, 31 mM
Citric Acid, 0.1% v/v Triton X-00, 1.85 mg/ml PNP substrate, pH
5.4) was added for 90 min at room temperature. After 100 ll of
2 M NaOH was added and the absorbance read at 405 nm (A405)
using a Fluostar Optima plate reader (BMG Labtech). Integrin
mediated platelet attachment was derived by subtracting
platelet derived absorbance in the presence of EDTA from the
platelet absorbance in the presence of Mg2+. Platelet adhesion
assays were performed in triplicate and values are reported as
means ± standard deviation.
2.9.3. HT1080 adhesion analysis
HT1080 cells derived from a human ﬁbrosarcoma were
obtained from the European Collection of Animal Cell Cultures,
Porton Down, UK. These were maintained in a humidiﬁed
incubator with 5% CO2 at 37 C in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Sigma–Aldrich) containing 10% fetal bovine
serum (Sigma–Aldrich) and 1% streptavidin/penicillin (Life
Technologies). Prior to cell adhesion experiments, HT1080s were
detached from the cell culture ﬂasks with 0.05% trypsin/0.02%
EDTA (GE Healthcare), washed and re-suspended in serum free
DMEM.
Collagen ﬁlms were BSA blocked as for platelet adhesion analy-
sis then 100 ll of HT1080 cells were added at a density of 5  105
cells/ml in serum free DMEM containing either 5 mM MgCl2 or
5 mM EDTA. After incubation at 37 C/5%CO2 for 40 min loosely
bound cells were removed with 3  200 ll PBS washes. Bound cells
were detected using the phosphatase substrate as for platelet
adhesion. Integrin mediated HT1080 attachment was derived by
subtracting attachment in the presence of EDTA from attachment
in the presence of Mg2+. Values indicate means of quadruplicate
measurements ± standard deviation.3. Results
3.1. Characterisation of collagen slurries
To assess the structural properties of collagen ﬁbre architecture,
two different tests were carried out: measurement of the apparent
viscosity of 1% (w/v) slurries, which should provide information
about molecular weight, and optical observation of collagen sus-
pensions after being treated with ﬂuorescently labelled GFOGER
triple-helical peptide, using a confocal microscope.3.1.1. Rheology
In order to gain insight into the macromolecular structure of
collagen from different suppliers (Devro and Sigma), the rheologi-
cal behaviour of 1% (w/v) suspensions in 0.05 M acetic acid was
studied. Col–Gel suspensions prepared from both Col samples
and pure Gel solution at 1% (w/v) were also tested under the same
conditions.
Fig. 1a shows the apparent viscosity of both collagen suspen-
sions as a function of the applied shear rate. It can be observed that
the value of the initial apparent viscosity of Sigma Col is over ten
times larger than that of Devro (180 and 12 Pa s, respectively) sug-
gesting that Sigma Col has a higher molecular weight. The level of
chain entanglement of the Sigma sample should also be much
higher leading to higher values of viscosity. With increase in shear
rate, both suspensions experience shear thinning, more evident in
the case of the Sigma sample. On increasing the shear rate, the
chains become disentangled, aligned and start to slide over each
other in non-Newtonian behaviour. At shear rates over 10 s1 both
Col samples became ﬂuid with very low viscosity values. The intro-
duction of Gel (50% w/w) to both types of Col (S and D) results in a
signiﬁcant fall in the initial apparent viscosity of both mixed com-
positions, this being more notable in Col(S)-Gel: from 180 to 6 Pa s
for Col (S) and Col (S)-Gel, respectively (Fig. 1b). Gelatin is dena-
tured collagen, with less organised structure and a shorter chain
length, which explains the very low values of the apparent viscos-
ity of its solutions. Incorporation of Gel into mixed compositions
should reduce the average molecular weight and therefore the
number of entanglements in the resultant suspensions, so decreas-
ing the energy required to orientate and align mixed Col–Gel
chains. The decrease in viscosity of the Sigma Col containing com-
position is so big that the differences in ﬂuidity between mixed
samples (Col(S)-Gel and Col(D)-Gel become less evident: 6 and
2 Pa s, for Sigma and Devro containing compositions, respectively.3.1.2. Confocal studies of peptide attachment to collagen ﬁbres
It has been showed that ﬂuorescein-labelled collagen-mimetic
peptides (GPO polymers) can bind to the ﬁbrils in polymeric ﬁbrous
collagen [43,44]. Some of us have shown that a ﬂuorescent version
of the integrin-binding peptide, GPC[GPP]5GFOGER[GPP]5GPC,
binds similarly to Ethicon collagen ﬁbres [40] thus allowing these
ﬁbres to be visualised using a confocal microscope. Observation of
how quickly the ﬂuorescence fades gives additional indirect infor-
mation about ﬁbre length/diameter. Confocal images of collagen
slurries, after attachment of the ﬂuorescently marked peptide, are
displayed in Fig. 2. Results show that the monomeric collagen
(Fig. 2A), as expected, does not bind GFOGER-FL, conﬁrming that
the ﬁbril structure is vital for attachment of this triple-helical pep-
tide to collagen [44]. Confocal observation of the macromolecular
structure of Col (D) revealed that the ﬂuorescence, due to peptide
attachment, faded almost immediately so that it was difﬁcult to
achieve good visualisation of its ﬁbre architecture (Fig. 2B). In con-
trast, ﬁbres of Sigma and Ethicon collagens (Fig. 2C and D) could be
clearly observed for a long period of time, indicating greater and
stronger attachment of GFOGER-FL. This may be due to the larger
Fig. 1. Dependence of the apparent viscosity (Pa s) of Col 1% (w/v) suspensions on shear rate (s1) for Sigma and Devro Type-I collagen at 20 C.
Fig. 2. Visualisation of internal structure of collagen suspensions after attachment of GFOGER-FL. Confocal images of different Col samples: (A) monomeric (negative control);
(B) Devro; (C) Sigma and (D) Ethicon (positive control). The scale bars are 100 lm.
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diameter/length there are more regions in the collagen chain for
peptide attachment [40]. Consistent with this hypothesis, Ethicon
showed the highest and most stable level of peptide binding
(Fig. 2D), as would be expected, therefore.
Another factor which might inﬂuence GFOGER-FL adsorption
may be related to the purity of Col samples. Other molecules that
remain after Col extraction may coat the ﬁbre surface and hinder
the attachment of peptide. The Ethicon sample was produced com-
mercially for wound dressing applications and may be more pure
than other collagens, which may also contribute to greater free
surface for GFOGER-FL binding and, therefore, visualisation.3.2. Morphology and dimensional properties of scaffolds
SEM images of non-XL samples displayed in Fig. 3 show highly
porous scaffolds with homogeneous isotropic inner architecture in
both longitudinal (Fig. 3A) and transversal (Fig. 3B) cross sections
for all scaffolds compositions. Only some pore enlargements on
the top and a narrow zone of pore densiﬁcation on the bottom of
scaffold sheet could be observed. The pore dimensions estimated
from SEM microphotographs were mostly in the range of
130–260 lm for all studied compositions and XL status. The varia-
tion in composition, Col type (S vs D) and XL status do not intro-
duce any appreciable changes in scaffold pore size (Fig. 3B).
Fig. 3. SEM images of scaffolds of different compositions and XL status: (A) non XL scaffolds (different longitudinal cross-sections), (B) inﬂuence of cross-linking and Col type
(transversal cross-sections).
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icant differences in values of dimensional characteristics were
detected for non-XL scaffolds of all compositions obtained from
both S and D Col. This result is to be expected since these param-
eters are mostly a function of the slurry concentration from which
the corresponding matrices were produced, and in all cases identi-
cal 1% (w/v) suspensions were employed to obtain the scaffolds. It
is interesting to note that the signiﬁcant differences in viscosity
between S and D collagens slurries had little effect on pore struc-
ture. Porosity of 99% was obtained for all compositions. These
values fall in a desirable range (generallyP 90%) required for 3D
cell supports designed for TE applications.
Dimensional parameters were also determined for EDC treated
samples of all compositions. Very similar values (99.1–99.2%) were
observed for both S and D Col-based scaffolds, mixed compositions
and pure Gel matrices after EDC cross-linking with standard condi-
tions (100%) indicating that EDC treatment does not affect porosity
values of 3D sponges. These results are in agreement with SEM
studies showed that composition and cross-linking have little
effect on the scaffold morphology.Table 1
Average values of density and porosity (pore volume fraction) of scaffolds obtained
from 1% (w/v) suspensions.
Composition Density (g/cm3) Relative density Pore volume fraction (%)
Col(D) 0.0110 ± 0.0003 0.0084 ± 0.0002 99.16 ± 0.02
Col(D)–Gel 0.0110 ± 0.0004 0.0085 ± 0.0003 99.15 ± 0.03
Col(S) 0.0108 ± 0.0001 0.0083 ± 0.0001 99.17 ± 0.01
Col(S)–Gel 0.0108 ± 0.0004 0.0083 ± 0.0003 99.17 ± 0.03
Gelatin 0.0112 ± 0.0006 0.0086 ± 0.0005 99.14 ± 0.05
Results are expressed as mean values of ﬁve parallel measurements ± standard
errors.3.3. Amine group content and degree of cross-linking
Proﬁles of the amount of free amine groups on lysine residues of
Col(S and D), mixed Col–Gel and Gel scaffolds before and after car-
bodiimide treatment with different EDC concentrations are dis-
played in Fig. 4. Non-XL Gel has a slightly higher number of free
amine groups compared to both Col (S and D) samples (33 and
26–27, respectively) and the increase in EDC concentration simi-
larly decreases the amount of free amine group on scaffolds of all
compositions and Col types.
After crosslinking with 100% EDC, the free amino group content
of all samples decreased signiﬁcantly, suggesting that the
crosslinking procedure was successful. The value of free amine
groups in all samples after crosslinking was 5–10. The principal
drop in this parameter occurred at EDC concentrations higher than
10%. Table 2 displays values of crosslinking degrees calculated
from the free amino group content after each treatment. These
results indicated that the percentage of crosslinking of all scaffolds
increased almost 4-fold with the increase of EDC concentration
from 10% to 100%. Similarities in the proﬁles of amino group con-
tent vs EDC concentration (Fig. 4a–c) suggest that neither the type
of Col (S vs D) nor the presence of Gel in scaffold composition sig-
niﬁcantly affect the extent of scaffold cross-linking reactions.3.4. Inﬂuence of EDC concentration and Col nature on scaffold
dissolution in water
The objective of this testing was to assess the possible effect of
the EDC concentration and the nature of employed Col on the scaf-
fold dissolution in aqueous environment. All scaffold compositions
(Col, Col–Gel and Gel) produced from both Col(S) and Col(D) sam-
ples were tested for stability in water. These extensive screening
Fig. 4. Inﬂuence of EDC concentration on the free amine group content on lysine residues of scaffolds of different compositions: (a) Sigma Col-based and Gel samples; (b)
Devro Col-based and Gel samples; (c) Col(S) vs Col(D) scaffolds. Results are mean values of three parallel measurements. Error bars represent the standard error.
Table 2
Degree of crosslinking of scaffolds calculated from free amino group content after
treatments with different EDC concentration.
EDC concentration Degree of crosslinking (%)
(%) Col(S) Col(D) Col(S)–Gel Col(D)–Gel Gel
100 81 ± 3 67 ± 5 80 ± 3 75 ± 3 69 ± 3
10 26 ± 10 18 ± 8 13 ± 4 16 ± 6 14 ± 4
1 8 ± 3 32 ± 9 2 ± 10 16 ± 5
0.1 0 ± 10 7 ± 6 1 ± 6
Results are expressed as mean values of three parallel measurements ± standard
errors.
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phate buffered saline or cell culture medium) for two main rea-
sons. Firstly, the effect of biological media and the presence of
enzymes (collagenase) on scaffold degradation behaviour for up
to prolonged incubation times has already been assessed in our
previous work (unpublished results) and secondly, using distilled
water as dissolution medium we avoid an additional sample han-
dling (washing up to 3 times in distilled water to ensure salt
removal before drying and weighing) which could alter scaffold
integrity, especially for weakly XL samples and after prolonged
time of incubation.
Both Col(S and D), mixed and pure Gel samples were tested for
their resistance to dissolution after EDC treatment with different
concentration. As an example of the effect of EDC crosslinking con-
centration on scaffold stability in water, the dissolution proﬁles for
Col(D)-type scaffolds, mixed compositions and Gel samples are
shown in Fig. 5. It could be observed that Col(D) and mixed scaf-
folds crosslinked with full (100%) and 10% EDC concentrations pos-
sess high resistance to dissolution over all studied period (up to
28d). Gel samples treated with the same crosslinking conditions
were also stable in water but for up to 14d. DD were very similar
and time independent for all compositions over a period of 14d
which is a sign of the high crosslinking density achieved by chem-
ical treatment with these conditions. Very low EDC concentrations
(0.1% and 1%) still could effectively stabilise Col(D) scaffolds (up to
14d) and at less extent mixed Col–Gel (up to 7d). Gel showed some
improvement in resistance to dissolution at 1% EDC after 1 h in
water (DD  40% comparing to complete dissolution of non XL
sample) but at 24 h mass loss was already very high (>65%).
The inﬂuence of Col nature on dissolution stability of EDC trea-
ted scaffolds could be observed in Figs. 6 and 7. Comparing results
in Fig. 6 with those in Fig. 5 it can be concluded that dissolution
proﬁles and DD values are very similar for both Col types (S and
D) over all incubation period (up to 28d) when these scaffolds
are treated with 10% and 100% EDC concentrations.
At lower EDC concentrations (0.1% and 1%) mass loss is similar
up to 7d and then Col(D) matrices gradually decrease their resis-
tance to dissolution while Col(S) samples are stable for up to 28d
when cross-linked with 1% EDC. Non-XL Col(S)-Gel scaffolds werealso more resistant to dissolution that mixed Col(D)-based samples
(60% and 80% of dissolution after 28d for Col(S) and
Col(D)-based matrices, respectively). The highlighted areas show
how similar degradation behaviour may be seen when the EDC
concentration is lowered from the standard 100% level.
Fig. 7a and b conﬁrm that EDC at concentration of 10% onward
can provide the same stability to Col scaffolds independently on
Col origin, to the mixed Col–Gel composition and to pure Gel scaf-
fold and that the differences in resistance to dissolution only
became evident with the decrease of EDC concentration, for both
pure Col and mixed compositions. At 14d all scaffolds show the
same DD degrees for EDC concentration of P10%. The decrease
in EDC content from 10% to 1% signiﬁcantly destabilised mixed
compositions (more noticeable in Col(D)-Gel samples) while pure
Gel matrices crosslinked with 1% EDC were completely solubilised
at this time point.3.5. Mechanical testing of different scaffold compositions
Compressive properties are of greater interest when studying
the impact of scaffold mechanics on cellular activity, because cells,
through their action, tend to bend and buckle individual struts
within the scaffold [32,45,46]. The linear elastic (Young’s) modulus
(E⁄) calculated from stress–strain analysis gives precisely the mea-
sure of the resistance of the struts to bending and buckling under
compression.
Mechanical testingwas carried out on all compositions (Col, Col–
Gel and Gel) treated with different EDC concentrations. Col(S) was
selected to assess the inﬂuence of different cross-linking treatments
on scaffold mechanics. The values of E⁄ for Sigma Col-containing
samples and pure Gel showed that EDC cross-linking at different
concentrations increases this parameter for all studied scaffolds
but to a different extent (Fig. 8). Gel samples treated with 1% EDC
were structurally too weak to be reliably assessed in compression.
All EDC-modiﬁed at standard cross-linking condition (11.5 mg/ml
EDC, 100%) matrices displayed the highest Young’s Modulus and
10-fold reduction in EDC/NHS concentrations still provides good
mechanical stability for Col-containing scaffolds compositions.
The introduction of Gel drastically decreases mechanical strength
of scaffolds even after crosslinking with maximum EDC
concentration.
To assess the scaffold’s behaviour under successive compres-
sions the same sample specimens were repeatedly compressed at
least three times and, in a case of Col(S), also after 10 days in water.
Example of stress–strain curves (Fig. 8b) corresponding to this test-
ing showed no signiﬁcant changes in their proﬁles up to a strain of
0.4 (curves almost overlay each other). Young’s moduli calculated
from the curves after successive compressions reveal, however,
some differences in scaffold elastic properties, more evident for
weakly EDC XL scaffolds. For example, Col scaffolds modiﬁed with
higher EDC concentration (10% or 100%) were very stable
Fig. 5. Inﬂuence of EDC concentration and composition on dissolution behaviour of Col(D)-based and Gel scaffolds. Results are mean values of four parallel measurements.
Error bars represent the standard error.
Fig. 6. Dissolution proﬁles of Col(S)-based scaffolds cross-linked with different EDC concentration. Results are mean values of four parallel measurements. Error bars
represent the standard error.
Fig. 7. Mass loss: (a) Col(S vs D) and (b) mixed Col(S vs D)-Gel and Gel scaffolds after 14d in water. Results are mean values of four parallel measurements. Error bars
represent the standard error.
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followed by one after 10d of incubation in water). No visual
changes were observed in Col pore structures though their E⁄ were
reduced in 20% and 30% for 10% and 100% EDC concentrations,
respectively. Elastic moduli of Col–Gel samples decreased in 30–
40% after third successive compression. The value of E⁄ for Col 1%
EDC XL samples experimented signiﬁcant decrease in 65% after
10d of incubation in water while 3D structures of non-XL Col and
Col–Gel or 1% EDC XL mixed Col–Gel scaffolds were too weak to
be accurately tested.
3.6. Cellular interactions
Platelets can adhere to collagen selectively through integrin
a2b1 but also a non-integrin receptor, GPIV. Therefore platelet bind-
ing is an ideal experimental system to measure the binding of an
individual integrin class, namely integrin a2b1, in isolation.Integrin a2b1 binding to collagen occurs through the high afﬁnity,
structurally sensitive GFOGER motif on triple helical collagen.
Therefore in order to determine if EDC crosslinking of the carboxylic
acid group on the E of GFOGER can inhibit integrin engagement
with this motif we measured integrin-mediated platelet binding
to collagen sample. This was achieved by subtracting the binding
observed in the presence of the cation chelator EDTA
(non-integrin-mediated binding) from the binding observed in
the presence of the integrin stimulating cation Mg2+
(integrin-mediated biding) (Fig. 9a). For this analysis thin ﬁlms
were prepared to mimic the 3D struts, mitigating complicating cel-
lular effects from a 3D system, allowing direct measurement of the
cell responses to chemically modiﬁed collagen. On Col(S) ﬁlms the
degree of integrin-mediated platelet adhesion was reduced by con-
ventional (100%) EDC crosslinking conditions compared to a
non-crosslinked control (Abs405 of 2.55 ± 0.07 and 0.23 ± 0.13 for
non-Xl and 100% EDC respectively). By contrast 1% or 10% of
Fig. 8. Inﬂuence of EDC concentration on the compressive modulus (E⁄) of the
scaffolds of different compositions (a) and typical proﬁles of compressive stress–
strain curves observed for hydrated Col(S) scaffolds after repeated compressions of
the same specimen over the entire strain range (e: 0–0.8) (b). Results are mean
values of ﬁve parallel measurements. Error bars represent the standard error.
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integrin-mediated platelet engagement with collagen ﬁlms, yield-
ing absorbances of 2.65 ± 0.06 and 2.60 ± 0.05 respectively.
Gelatin incorporation reduced integrin a2b1-mediated platelet
interactions with the resulting Col(S)-Gel samples compared to
Col(S) (Abs405 of 1.12 ± 0.08). Crosslinking with 1% or 10%
EDC/NHS did not alter the degree of integrin-mediated platelet
adhesion whereas crosslinking with 100% EDC/NHS signiﬁcantly
inhibited integrin-mediated platelet adhesion to Col(S)–Gel ﬁlms
giving an absorbance of 0.048 ± 0.08. It should be noted that this
negative reading is a result of a slightly higher absorbance for the
EDTA treated platelets than the Mg2+ treated platelets. The extreme
solubility of Gel restricted platelet binding analysis to 10% and 100%
EDC crosslinked samples. These bound to approximately the same
number of platelets as the mixed composition Col(S)–Gel which
was not sensitive to 10% or 100% EDC crosslinking.
HT1080 cells utilise integrin a2b1 exclusively for binding to
GFOGER making them an ideal system to analyse cell-associated
integrin 21 interactions with collagen ﬁlms. As gelatin incorpora-
tion reduced the level of integrin mediated platelet adhesion the
Col(S)-Gel and Gel samples were not further analysed. Instead
Col(S) alone was used to determine the inﬂuence of EDC crosslink-
ing on HT1080 ﬁbrosarcoma cell adhesion. HT1080 cell adhesion to
Col(S) was inhibited from 1.35 ± 0.06 on non-crosslinked Col(S) to
0.18 on 100% EDC/NHS crosslinked (Fig. 9b). By contrast 10%
EDC/NHS crosslinking only moderately affected integrin mediated
HT1080 cell attachment giving an absorbance of 0.98 ± 0.04.
Together these date indicate that by utilising lower EDC/NHS
crosslinking conditions it is possible to preserve native-like inte-
grin 21 mediated cell interactions with collagen-based materials.4. Discussion
4.1. Characteristics of collagen suspensions
Rheological and peptide binding studies indicate that signiﬁ-
cant differences exist in the ﬁbre length and diameter of collagen
depending upon its origin. The Sigma sample possesses a higher
molecular weight with greater ﬁbre diameter than that of Devro.
Although both collagen samples are of bovine type, Sigma was
extracted from bovine Achilles tendon, a high load tissue, particu-
larly resistant to tension, while Devro was derived from dermal tis-
sue, which is soft, ﬂexible and only sustains lower loads. Tendon
collagen can be extracted in quite good purity simply by dissection,
whereas skin collagens require more complex processing, and ten-
don ﬁbres are known to be quite long and of large diameter. These
changes in tissue properties, as well as in extraction/puriﬁcation
methods, may explain the differences found in the macromolecular
parameters and organisation of collagen chains of Sigma and Devro
samples. This, in turn, may explain the differences in the material
properties of scaffolds produced from these collagen samples, such
as their degradation degree and resistance to compression.4.2. Morphology
It is well known that polymer scaffolds for use in cell culture
must be highly porous with large surface/volume ratios to provide
sufﬁcient space for cell growth and proliferation [32]. The pore size
and interconnectivity are important in allowing cell inﬁltration,
vascularisation and the diffusion of nutrients and oxygen, and
the scaffold porosity should be high and interconnected to prevent
obstruction of the material, which may lead to necrosis in vivo
[47,48]. Scaffold production conditions chosen in this work
allowed highly porous (porosity 99%) 3D scaffolds with intercon-
nected inner architecture to be obtained for all compositions stud-
ied. The pore diameters, similar for all scaffolds, were mostly
between 130 and 260 lm. Crosslinking with EDC has not signiﬁ-
cantly altered the scaffold inner architecture in such a way as to
produce a detrimental effect on pore size and porosity. The pore
size was within a range suitable for the growth of myocytes,
endothelial cells and ﬁbroblasts as reported in previous research
[48–50]. This means that the morphology of all protein matrices
was appropriate for their use in myocardial TE applications.4.3. Amine group analysis and cell interactions
Estimation of the free amino group content of all scaffold com-
positions under different XL conditions allowed the extension of
EDC-mediated bonding in macromolecular chains of proteins to
be monitored and controlled. It was shown that, by varying EDC
content, scaffolds with a variety of crosslinking degrees could be
obtained, and that this process was almost independent of Col
precedence (S or D) and Gel addition. The consumption of free
amine groups during EDC-treatment should result in proportional
reduction of free carboxylate anions on glutamate or aspartate
residues (according to XL mechanism). This in turn might lead to
the reduction of the availability of cell binding sites on scaffold
proteins with the consequent impact on the biological properties
of the resultant samples. Notably, EDC treatment could modify
the E on the cell binding GFOGERmotif in collagen that bind specif-
ically to the four collagen-binding integrins. Furthermore, EDC
could modify the RGD motifs that are present, but sterically hin-
dered from integrin binding, in the latent form in collagen but
become active on denaturation (in gelatin) and become competent
to bind some of the ﬁbronectin-binding integrins [51].
Fig. 9. Integrin mediated platelet (a) and HT1080 cell (b) attachment to ﬁlms prepared from sigma collagen (Col(S) – black bars), 50:50 sigma collagen:gelatin (Col(S):Gel –
dark grey bars) and gelatin (Gel – light grey bars) treated with increasing concentrations of EDC where 100% equates to 2:5:1 M ratio of EDC:NHS:collagen COOH groups.
Results are mean values of quadruplicate measurements. Error bars represent standard deviation from the mean.
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motifs on collagen-based samples was tested by platelet and
HT1080 ﬁbrosarcoma binding assays. Both cell types bind to colla-
gen via integrin 21 which is sensitive to the presence of the GFOGER
motif. These showed that integrin 21 dependent cell attachment to
collagen was ablated by 100% EDC conditions, supporting the con-
clusion that EDC treatment chemically modiﬁes integrin-binding
sites on the collagen-based materials. To compensate a 10-fold
lower EDC crosslinking regime can be utilised, allowing full plate-
let and increased HT1080 integrin-mediated interactions. Addition
of gelatin to the collagen composition reduced the degree of
integrin mediated platelet binding. This is presumably due to the
effective dilution of triple helical GFOGER motifs on the native col-
lagen with the addition of RGD motifs in gelatin. As for pure Col(S)
compositions, 100% EDC crosslinking ablated platelet attachment
but lower EDC conditions (610%) allowed comparable platelet
attachment to the non-XL controls. Therefore the cell attachment
data are in agreement with the amine content analysis showing
that consuming amine groups, and by extension carboxylic acid
groups such as on the E of GFOGER, impacts on the bioactivity of
the resultant materials. This data provides a maximal degree of
side chain consumption that is compatible with bioactivity. In
the case of Col(S) compositions this equates to 26% of amine
crosslinking using a molar ratio of 0.5 EDC:0.2 NHS:1 COO(Col)
to retain cellular biorecognition.
4.4. Dissolution in water
Results of dissolution studies in water showed that EDC treat-
ment at concentration of 10% onwards effectively stabilised all
studied compositions, almost independently of Gel presence or
Col origin which is in agreement with the results of degrees of
cross-linking calculated from the free amino group content. The
nature of the Col employed plays a signiﬁcant role in scaffold sta-
bility only for untreated matrices or for those cross-linked withvery low EDC concentration (1% or less). The presence of Gel
requires a higher concentration of carbodiimide to provide stability
of mixed or pure Gel compositions to prevent loss of scaffold mate-
rial to the media at prolonged incubation times in an aqueous envi-
ronment. Scaffolds obtained from Sigma Col are relatively stable in
a wet environment even without additional chemical treatment
and may be employed without EDC cross-linking for their use as
cell supports for up to 7 days. The differences in dissolution prop-
erties between D and S collagens are more evident at lower EDC. By
changing EDC concentrations further control over the degradation
kinetics may be achieved. Variation of the Col origin opens an addi-
tional way of tuning/tailoring the ﬁnal properties of Col-based
scaffolds towards speciﬁc TE applications.
4.5. Compression modulus
It has already been demonstrated that scaffold microstructure
and stiffness affects the bioactivity of these systems [52].
Previous studies into the mechanical stiffness and strength have
shown that these properties were increased after scaffold
crosslinking [1,2,6,10,37,46]. Tests, conducted in this study on
the effect of the EDC XL conditions on the mechanical performance
of scaffolds revealed that both crosslinking density and composi-
tion have signiﬁcant impact on the compressive modulus (E⁄) of
the resultant 3D matrices. EDC treated Col scaffolds exhibited
higher values of these parameters compared to Gel-containing
samples and the increase in EDC concentration enhanced the val-
ues of E⁄. It is known that the Young’s modulus of 3D scaffolds
depends upon the relative density of the sponge, the elastic mod-
ulus of struts (solid from which scaffolds are made) and a constant
related to the pore geometry. As relative density and cell geometry
are the same for all samples (no changes in morphology and
dimensional properties were found after EDC treatment for all
compositions) it is logical to assume that the increase in strut stiff-
ness is a results of variations in composition (from Gel to Col) and
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within scaffold struts induced by EDC.5. Conclusions
This research addresses the question of how the composition
and crosslinking of collagenous biomaterials affect their physical
properties and the number of cell binding sites on glutamate or
aspartate residues (proportional to free amine groups on lysine
residues), crucial for integrin mediated cell adhesion to scaffold
surfaces. Highly porous (porosity 99%) Col (from different suppli-
ers), Gel and mixed Col–Gel (50–50% wt.) 3D matrices with homo-
geneous inner architecture and average pore diameter (130–
260 lm), suitable for soft tissue TE, were produced using a freeze
drying technique. The effect of Col origin and of the variation of
EDC crosslinking conditions (down to very low EDC content) on
the morphology and the relevant material properties of scaffolds
of different composition was established. Characterisation of Col
slurries, obtained from Col from different suppliers (Sigma vs
Devro), in terms of rheological properties and peptide attachment
to Col ﬁbres, allowed insight into their macromolecular structure
and provided an explanation for the results of material testing. It
was shown that scaffold mechanics was highly dependent upon
the EDC content for all compositions, and that in order to achieve
stable resistance under successive compressions the 3D matrices
should be treated with 10% EDC or more, especially in the case of
Gel-derived samples. It was also found that irrespective of the scaf-
fold constituents used, it was possible to reduce the amount of EDC
by at least 10 times without loss of scaffold stability in water.
Consistent with the lower chemical modiﬁcation of vital carboxylic
acid groups, this 10-fold reduction in EDC crosslinking permitted
integrin mediated cell interactions with the scaffold. It may be con-
cluded, therefore, that variation of EDC concentration provides a
simple method of modulation of the physical and biological prop-
erties of scaffold material. Further tuning of scaffold chemistry,
mechanics and biological characteristics may be achieved by
changing Col origin and/or introducing Gel to the scaffold
composition.
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